Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Upstarts can't wait to leave university

13 April 2012

[image reference is broken]

There has never been a better time for students to start their own firms writes Catherine Wheatley, The Sunday Times.

UCL was featured in an article in the Small Business section of The Sunday Times.

Ahmad Bakhiet, President of the UCL Enterprise Society comments and UCL was mentioned for hosting the London Launch 48 event earlier this year.

There is plenty of evidence that students attitudes are already changing with more enterprise clubs and incubators springing up on campuses than ever before.

Ahmad Bakhiet, President of the UCL Enterprise Society comments:
"The scene has grown a lot in the past couple of years… Once these people would have gone into investment banking; now they want to start their own businesses. Enterprise is seen as a viable career choice."


Links: